Sort   by:  
 Page size 
ProteomicsPTAFR is the receptor of PRXL2A
We designed an experiment and discovered that PTAFR is the specific membrane surface receptor for PRXL2A.
ORGANISM(S): Mus musculus (Mouse) 
2024-09-17 | PXD053615 | Pride
Ptafr  receptor  prxl2a 
UnknownIdentifying PTAFR as a hub gene in atherosclerosis: implications for NETosis and disease progression.
Not available
S-EPMC11663315 | biostudies-literature
GenomicsEffect of Hyperoxia Exposure on the Neonatal Lungs of WT C57BL6 and PTAFR KO C57BL6 mice
Effect of Hyperoxia Exposure on the Neonatal Lungs of WT C57BL6 and PTAFR KO C57BL6 mice
PRJNA948349 | ENA
TranscriptomicsEffect of Hyperoxia Exposure on the Neonatal Lungs of WT C57BL6 and PTAFR KO C57BL6 mice
To assess the role of signaling via platelet-activating factor (PAF) in a murine model of BPD, we used WT and PTAFR KO mice on a C57BL6 background
ORGANISM(S): Mus musculus 
2024-03-23 | GSE228125 | GEO
UnknownKadsurenone is a useful and promising treatment strategy for breast cancer bone metastases by blocking the PAF/PTAFR signaling pathway.
Not available
S-EPMC6036417 | biostudies-literature
Unknown<i>Ardisia japonica</i> (Thunb.) Blume and <i>Lespedeza cuneata</i> G. Don may treat chronic obstructive pulmonary disease by targeting HK2 and PTAFR.
Not available
S-EPMC12090870 | biostudies-literature
UnknownNuclear localization of platelet-activating factor receptor controls retinal neovascularization.
Not available
S-EPMC4941644 | biostudies-literature
UnknownPlatelet-activating factor receptor affects food intake and body weight.
Not available
S-EPMC5773056 | biostudies-literature
Methylation profilingEpigenome analysis of human gastroesophageal junction (GEJ) organoids TP53/CDKN2A KO
Inactivation of the tumor suppressor genes TP53 and CDKN2A occurs early during GEJ tumorigenesis. However, due to a paucity of GEJ-specific disease models, cancer-promoting consequences of TP53 and CDKN2A inactivation at the GEJ have been incompletely characterized. Here we report the development of...
ORGANISM(S): Homo sapiens 
2022-11-02 | GSE216814 | GEO
TranscriptomicsGene expression profile of human gastroesophageal junction (GEJ) organoids TP53/CDKN2A KO
Inactivation of the tumor suppressor genes TP53 and CDKN2A occurs early during GEJ tumorigenesis. However, due to a paucity of GEJ-specific disease models, cancer-promoting consequences of TP53 and CDKN2A inactivation at the GEJ have been incompletely characterized. Here we report the development of...
ORGANISM(S): Homo sapiens 
2025-10-20 | GSE216198 | GEO
Sort   by:  
 Page size